Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

Clinical trial NCT00228566 · COMPLETED

Trial details

NCT number: NCT00228566
Sponsor: Cephalon
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Excessive Daytime Sleepiness Narcolepsy Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS)

Start date: 2005-10-01
Enrollment: 247

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.